BPI 2026 · Biotech

Kyverna Therapeutics at BPI 2026

Emeryville, California

Kyverna Therapeutics brings 2 presentations to BPI 2026 in Boston. Its program centres on cell therapies for autoimmune disease and how to manufacture them at scale. One session describes development of next-generation cell therapies for autoimmune disease, and another draws lessons for faster, more affordable ex vivo cell therapy manufacturing.

OrganizationBPI 2026 Attendance
Kyverna Therapeutics
Emeryville, California
1 CTO
kyvernatx.com
Biotech
Clinical-stage biotechnology company developing CAR T-cell therapies for autoimmune diseases.
Panel
Thu Sep 24
9:30am–10:30am
Keynote Panel Discussion: Scaling Cell Therapies- Lessons from Pioneers for Smarter, Faster, and More Affordable Ex Vivo Cell Therapy Manufacturing
Cell Therapy Manufacturing & Analytics · with Iovance Biotherapeutics, Novartis, L7 Informatics
Talk
Fri Sep 25
11:15am–11:35am
Development of Next Generation Cell Therapies for Autoimmune Disease
Development of Emerging Cell & Gene Therapies

Explore the full BPI 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full BPI 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Kyverna Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction